Baker Bros. Advisors LP G1 Therapeutics, Inc. Transaction History

Baker Bros. Advisors LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 14, 2020	SELL	$9.57 - $24.37 $842,408 - $2.15 Million	-88,026 Closed	0 $0
Q1 2020 May 15, 2020	SELL	$9.07 - $26.32 $355,634 - $1.03 Million	-39,210 Reduced 30.82%	88,026 $970,000
Q3 2018 Nov 14, 2018	SELL	$43.15 - $67.97 $1.82 Million - $2.87 Million	-42,256 Reduced 24.93%	127,236 $6.65 Million
Q1 2018 May 15, 2018	BUY	$19.05 - $41.76 $3.23 Million - $7.08 Million	169,492 New	169,492 $6.28 Million

101

20.1M

1.87M

1.18M

Ticker GTHX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,746,800
Market Cap $306M
Description
G1 Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of small molecule therapeutics for the treatment of patients with cancer. The company offers COSELA, which helps to decrease chemotherapy-induced myelosuppression in adult patients when administered prior to a platinum/...

Get notified when there are updates to the investment portfolio of Baker Bros. Advisors LP, based on Form 13F filings with the SEC.

Stay updated on Baker Bros. Advisors LP with notifications on news.